Primary Site >> Pancreatic Cancer

Gene >> PIK3CA

Journal: Oncogene. 1999 Sep 2;18(35):4891-8.
Title: Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2.
Author: Mitsuuchi, Y|Johnson, S W|Sonoda, G|Tanno, S|Golemis, E A|Testa, J R
PMID: 10490823
Journal: Clin Cancer Res. 2005 Apr 15;11(8):2875-8.
Title: Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
Author: Levine, Douglas A|Bogomolniy, Faina|Yee, Cindy J|Lash, Alex|Barakat, Richard R|Borgen, Patrick I|Boyd, Jeff
PMID: 15837735
Journal: Clin Cancer Res. 2006 Jun 15;12(12):3851-5.
Title: PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
Author: Schonleben, Frank|Qiu, Wanglong|Ciau, Nancy T|Ho, Daniel J|Li, Xiaojun|Allendorf, John D|Remotti, Helen E|Su, Gloria H
PMID: 16778113
Journal: Hum Mutat. 2008 Feb;29(2):284-8.
Title: PIK3CA cancer mutations display gender and tissue specificity patterns.
Author: Benvenuti, Silvia|Frattini, Milo|Arena, Sabrina|Zanon, Carlo|Cappelletti, Vera|Coradini, Danila|Daidone, Maria Grazia|Pilotti, Silvana|Pierotti, Marco A|Bardelli, Alberto
PMID: 18022911
Journal: Langenbecks Arch Surg. 2008 May;393(3):289-96.
Title: PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.
Author: Schonleben, Frank|Qiu, Wanglong|Remotti, Helen E|Hohenberger, Werner|Su, Gloria H
PMID: 18343945
Journal: Cancer Res. 2008 Apr 15;68(8):2841-9.
Title: Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.
Author: Jimeno, Antonio|Tan, Aik Choon|Coffa, Jordy|Rajeshkumar, N V|Kulesza, Peter|Rubio-Viqueira, Belen|Wheelhouse, Jenna|Diosdado, Begona|Messersmith, Wells A|Iacobuzio-Donahue, Christine|Maitra, Anirban|Varella-Garcia, Marileila|Hirsch, Fred R|Meijer, Gerrit
PMID: 18413752
Journal: Oncogene. 2008 Sep 18;27(42):5648-50.
Title: AKT1(E17K) in human solid tumours.
Author: Bleeker, F E|Felicioni, L|Buttitta, F|Lamba, S|Cardone, L|Rodolfo, M|Scarpa, A|Leenstra, S|Frattini, M|Barbareschi, M|Grammastro, M Del|Sciarrotta, M G|Zanon, C|Marchetti, A|Bardelli, A
PMID: 18504432
Journal: PLoS One. 2009 Oct 14;4(10):e7464.
Title: Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells.
Author: Soh, Junichi|Okumura, Naoki|Lockwood, William W|Yamamoto, Hiromasa|Shigematsu, Hisayuki|Zhang, Wei|Chari, Raj|Shames, David S|Tang, Ximing|MacAulay, Calum|Varella-Garcia, Marileila|Vooder, Tonu|Wistuba, Ignacio I|Lam, Stephen|Brekken, Rolf|Toyooka, Shinic
PMID: 19826477
Journal: Clin Cancer Res. 2010 Oct 15;16(20):4928-37.
Title: Key role of phosphoinositide 3-kinase class IB in pancreatic cancer.
Author: Edling, Charlotte E|Selvaggi, Federico|Buus, Richard|Maffucci, Tania|Di Sebastiano, Pierluigi|Friess, Helmut|Innocenti, Paolo|Kocher, Hemant M|Falasca, Marco
PMID: 20876794
Journal: Biol Pharm Bull. 2010;33(8):1261-7.
Title: Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.
Author: Gong, Xiao-Guang|Lv, Yun-Fu|Li, Xin-Qiu|Xu, Fu-Guo|Ma, Qing-Yong
PMID: 20686216
Journal: Am J Surg Pathol. 2011 Dec;35(12):1812-7.
Title: Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas.
Author: Yamaguchi, Hiroshi|Kuboki, Yuko|Hatori, Takashi|Yamamoto, Masakazu|Shiratori, Keiko|Kawamura, Shunji|Kobayashi, Makio|Shimizu, Michio|Ban, Shinichi|Koyama, Isamu|Higashi, Morihiro|Shin, Nobuhiro|Ishida, Kazuyuki|Morikawa, Takanori|Motoi, Fuyuhiko|Unno, Mi
PMID: 21945955
Journal: Mol Cancer Ther. 2011 Dec;10(12):2426-36.
Title: GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.
Author: Wallin, Jeffrey J|Edgar, Kyle A|Guan, Jane|Berry, Megan|Prior, Wei Wei|Lee, Leslie|Lesnick, John D|Lewis, Cristina|Nonomiya, Jim|Pang, Jodie|Salphati, Laurent|Olivero, Alan G|Sutherlin, Daniel P|O'Brien, Carol|Spoerke, Jill M|Patel, Sonal|Lensun, Letitia|
PMID: 21998291
Journal: J Gastroenterol. 2012 Feb;47(2):203-13.
Title: Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.
Author: Mohri, Dai|Asaoka, Yoshinari|Ijichi, Hideaki|Miyabayashi, Koji|Kudo, Yotaro|Seto, Motoko|Ohta, Miki|Tada, Motohisa|Tanaka, Yasuo|Ikenoue, Tsuneo|Tateishi, Keisuke|Isayama, Hiroyuki|Kanai, Fumihiko|Fukushima, Noriyoshi|Tada, Minoru|Kawabe, Takao|Omata, Mas
PMID: 22041919
Journal: Cancer Med. 2012 Oct;1(2):207-17.
Title: Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer.
Author: Arcaroli, John|Quackenbush, Kevin|Dasari, Arvind|Powell, Rebecca|McManus, Martine|Tan, Aik-Choon|Foster, Nathan R|Picus, Joel|Wright, John|Nallapareddy, Sujatha|Erlichman, Charles|Hidalgo, Manuel|Messersmith, Wells A
PMID: 23342270
Journal: Clin J Gastroenterol. 2012 Dec;5(6):413-20.
Title: Intraductal tubulopapillary neoplasm of the pancreas with somatic BRAF mutation.
Author: Urata, Takahiro|Naito, Yoshiki|Nagamine, Michiko|Izumi, Yoshihiro|Tonaki, Ginga|Iwasaki, Hajime|Sasaki, Akiko|Yamasaki, Akira|Minami, Nobuhiro|Yoshioka, Rituko|Kitada, Hideki|Takekuma, Yoshi|Yokomizo, Hiroshi|Fukuda, Seiji|Yamaguchi, Hiroshi|Kuboki, Yuko|
PMID: 26181322
Journal: Oncotarget. 2013 Feb;4(2):277-88.
Title: Efemp1 and p27(Kip1) modulate responsiveness of pancreatic cancer cells towards a dual PI3K/mTOR inhibitor in preclinical models.
Author: Diersch, Sandra|Wenzel, Patrick|Szameitat, Melanie|Eser, Philipp|Paul, Mariel C|Seidler, Barbara|Eser, Stefan|Messer, Marlena|Reichert, Maximilian|Pagel, Philipp|Esposito, Irene|Schmid, Roland M|Saur, Dieter|Schneider, Gunter
PMID: 23470560
Journal: Clin Cancer Res. 2013 Dec 15;19(24):6830-41.
Title: Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.
Author: Garcia-Carracedo, Dario|Turk, Andrew T|Fine, Stuart A|Akhavan, Nathan|Tweel, Benjamin C|Parsons, Ramon|Chabot, John A|Allendorf, John D|Genkinger, Jeanine M|Remotti, Helen E|Su, Gloria H
PMID: 24132918
Journal: Cancer Cytopathol. 2013 Dec;121(12):688-94.
Title: Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Author: Young, Geneva|Wang, Kai|He, Jie|Otto, Geoff|Hawryluk, Matthew|Zwirco, Zac|Brennan, Tina|Nahas, Michelle|Donahue, Amy|Yelensky, Roman|Lipson, Doron|Sheehan, Christine E|Boguniewicz, Ann B|Stephens, Philip J|Miller, Vincent A|Ross, Jeffrey S
PMID: 23893923
Journal: Mol Cancer Ther. 2013 Jun;12(6):853-64.
Title: Bcl-2/Bcl-xL inhibition increases the efficacy of MEK inhibition alone and in combination with PI3 kinase inhibition in lung and pancreatic tumor models.
Author: Tan, Nguyen|Wong, Maureen|Nannini, Michelle A|Hong, Rebecca|Lee, Leslie B|Price, Stephen|Williams, Karen|Savy, Pierre Pascal|Yue, Peng|Sampath, Deepak|Settleman, Jeffrey|Fairbrother, Wayne J|Belmont, Lisa D
PMID: 23475955
Journal: J Gastrointest Oncol. 2013 Mar;4(1):20-9.
Title: Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma.
Author: Weiss, Guy A|Rossi, Michael R|Khushalani, Nikhil I|Lo, Ken|Gibbs, John F|Bharthuar, Anubha|Cowell, John K|Iyer, Renuka
PMID: 23450128
Journal: Diagn Pathol. 2014 Jan 20;9:11.
Title: Case report: Intraductal tubulopapillary neoplasm of the pancreas with unique clear cell phenotype.
Author: Ahls, Maria Gabriele|Niedergethmann, Marco|Dinter, Dietmar|Sauer, Christian|Luttges, Jutta|Post, Stefan|Marx, Alexander|Gaiser, Timo
PMID: 24443801
Journal: Pancreas. 2014 Mar;43(2):245-9.
Title: PIK3CA mutations in mucinous cystic neoplasms of the pancreas.
Author: Garcia-Carracedo, Dario|Chen, Zong-Ming|Qiu, Wanglong|Huang, Alicia S|Tang, Sophia M|Hruban, Ralph H|Su, Gloria H
PMID: 24518503
Journal: BMC Cancer. 2014 May 25;14:370.
Title: Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway.
Author: Shi, Pengfei|Yin, Tao|Zhou, Feng|Cui, Pengfei|Gou, Shanmiao|Wang, Chunyou
PMID: 24885711
Journal: Mol Ther. 2014 Dec;22(12):2056-68.
Title: Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies.
Author: Ranzani, Marco|Annunziato, Stefano|Calabria, Andrea|Brasca, Stefano|Benedicenti, Fabrizio|Gallina, Pierangela|Naldini, Luigi|Montini, Eugenio
PMID: 25195596
Journal: Gastroenterology. 2014 Dec;147(6):1405-16.e7.
Title: PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
Author: Wu, Chia-Yen C|Carpenter, Eileen S|Takeuchi, Kenneth K|Halbrook, Christopher J|Peverley, Louise V|Bien, Harold|Hall, Jason C|DelGiorno, Kathleen E|Pal, Debjani|Song, Yan|Shi, Chanjuan|Lin, Richard Z|Crawford, Howard C
PMID: 25311989
Journal: Front Physiol. 2014 Oct 15;5:391.
Title: Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts.
Author: Falasca, Marco|Maffucci, Tania
PMID: 25360116
Journal: Oncotarget. 2015 Mar 10;6(7):4553-61.
Title: Molecular landscape of pancreatic cancer: implications for current clinical trials.
Author: Heestand, Gregory M|Kurzrock, Razelle
PMID: 25714017
Journal: Transl Oncogenomics. 2015 Nov 23;7(Suppl 1):13-31.
Title: c-Met as a Target for Personalized Therapy.
Author: Garajova, Ingrid|Giovannetti, Elisa|Biasco, Guido|Peters, Godefridus J
PMID: 26628860
Journal: Pathol Res Pract. 2015 Dec;211(12):1034-9.
Title: A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?
Author: Muraki, Takashi|Uehara, Takeshi|Sano, Kenji|Oota, Hiroyoshi|Yoshizawa, Akihiko|Asaka, Shiho|Tateishi, Ayako|Otsuki, Toshiaki|Shingu, Kunihiko|Matoba, Hisanori|Kobayashi, Shota|Ichimata, Shojiro|Watanabe, Takayuki|Itou, Tetsuya|Tanaka, Eiji
PMID: 26586167
Journal: Int J Clin Exp Pathol. 2015 Aug 1;8(8):9672-80. eCollection 2015.
Title: Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature.
Author: Kolby, David|Thilen, Johan|Andersson, Roland|Sasor, Agata|Ansari, Daniel
PMID: 26464736
Journal: Oncogenesis. 2015 Oct 5;4:e169.
Title: PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors.
Author: Payne, S N|Maher, M E|Tran, N H|Van De Hey, D R|Foley, T M|Yueh, A E|Leystra, A A|Pasch, C A|Jeffrey, J J|Clipson, L|Matkowskyj, K A|Deming, D A
PMID: 26436951
Journal: Gastroenterology. 2015 Nov;149(6):1501-10.
Title: A combination of molecular markers and clinical features improve the classification of pancreatic cysts.
Author: Springer, Simeon|Wang, Yuxuan|Dal Molin, Marco|Masica, David L|Jiao, Yuchen|Kinde, Isaac|Blackford, Amanda|Raman, Siva P|Wolfgang, Christopher L|Tomita, Tyler|Niknafs, Noushin|Douville, Christopher|Ptak, Janine|Dobbyn, Lisa|Allen, Peter J|Klimstra, David
PMID: 26253305
Journal: Ann Oncol. 2015 Sep;26(9):1923-9.
Title: A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Author: O'Neil, B H|Scott, A J|Ma, W W|Cohen, S J|Leichman, L|Aisner, D L|Menter, A R|Tejani, M A|Cho, J K|Granfortuna, J|Coveler, A L|Olowokure, O O|Baranda, J C|Cusnir, M|Phillip, P|Boles, J|Nazemzadeh, R|Rarick, M|Cohen, D J|Radford, J|Fehrenbacher, L|Bajaj, R
PMID: 26091808
Journal: Oncotarget. 2015 Mar 30;6(9):7209-20.
Title: Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.
Author: Mitsuhashi, Kei|Nosho, Katsuhiko|Sukawa, Yasutaka|Matsunaga, Yasutaka|Ito, Miki|Kurihara, Hiroyoshi|Kanno, Shinichi|Igarashi, Hisayoshi|Naito, Takafumi|Adachi, Yasushi|Tachibana, Mami|Tanuma, Tokuma|Maguchi, Hiroyuki|Shinohara, Toshiya|Hasegawa, Tadashi|I
PMID: 25797243
Journal: Nature. 2015 Feb 26;518(7540):495-501.
Title: Whole genomes redefine the mutational landscape of pancreatic cancer.
Author: Waddell, Nicola|Pajic, Marina|Patch, Ann-Marie|Chang, David K|Kassahn, Karin S|Bailey, Peter|Johns, Amber L|Miller, David|Nones, Katia|Quek, Kelly|Quinn, Michael C J|Robertson, Alan J|Fadlullah, Muhammad Z H|Bruxner, Tim J C|Christ, Angelika N|Harliwong,
PMID: 25719666
Journal: Virchows Arch. 2015 Feb;466(2):237-41.
Title: Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity.
Author: Szasz, A Marcell|Szirtes, Ildiko|Tihanyi, Balazs|Barkaszi, Bernadett|Baranyai, Zsolt|Tihanyi, Tibor|Harsanyi, Laszlo|Timar, Jozsef|Kulka, Janina
PMID: 25432630
Journal: Oncotarget. 2015 Mar 10;6(7):4553-61.
Title: Molecular landscape of pancreatic cancer: implications for current clinical trials.
Author: Heestand, Gregory M|Kurzrock, Razelle
PMID: 11051691
Journal: Cancer Genet. 2015 Sep;208(9):441-7.
Title: Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach.
Author: Hagemann, Ian S|O'Neill, Patrick K|Erill, Ivan|Pfeifer, John D
PMID: 26227479
Journal: Oncotarget. 2016 Nov 15;7(46):74797-74806.
Title: Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression.
Author: Durante, Sandra|Vecchiarelli, Silvia|Astolfi, Annalisa|Grassi, Elisa|Casadei, Riccardo|Santini, Donatella|Panzacchi, Riccardo|Ricci, Claudio|Serravalle, Salvatore|Tarantino, Giuseppe|Falconi, Mirella|Teti, Gabriella|Indio, Valentina|Pession, Andrea|Minni,
PMID: 27566563
Journal: Genet Mol Res. 2016 Jul 29;15(3). pii: gmr6991.
Title: Abnormal expression of PTEN and PIK3CA in pemetrexed-resistant human pancreatic cancer cell line Patu8988.
Author: Shi, X|Gu, H T|Lin, S B|Zhang, Y|Yang, J|Qian, C J
PMID: 27525871
Journal: Bull Cancer. 2016 Jul-Aug;103(7-8):643-50.
Title: [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "a la carte" treatment?].
Author: Dreyer, Chantal|Afchain, Pauline|Trouilloud, Isabelle|Andre, Thierry
PMID: 27345450
Journal: Clin Cancer Res. 2016 Dec 1;22(23):5805-5817.
Title: Therapeutic Benefit of Selective Inhibition of p110alpha PI3-Kinase in Pancreatic Neuroendocrine Tumors.
Author: Soler, Adriana|Figueiredo, Ana M|Castel, Pau|Martin, Laura|Monelli, Erika|Angulo-Urarte, Ana|Mila-Guasch, Maria|Vinals, Francesc|Baselga, Jose|Casanovas, Oriol|Graupera, Mariona
PMID: 27225693
Journal: Mol Cancer Ther. 2016 May;15(5):985-97.
Title: Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.
Author: Puskas, Laszlo G|Man, Imola|Szebeni, Gabor|Tiszlavicz, Laszlo|Tsai, Susan|James, Michael A
PMID: 26939707
Journal: Med Oncol. 2016 Apr;33(4):32.
Title: KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review.
Author: Zhou, Lei|Baba, Yoshifumi|Kitano, Yuki|Miyake, Keisuke|Zhang, Xiaobo|Yamamura, Kensuke|Kosumi, Keisuke|Kaida, Takayoshi|Arima, Kota|Taki, Katsunobu|Higashi, Takaaki|Imai, Katsunori|Hashimoto, Daisuke|Yamashita, Yoichi|Chikamoto, Akira|Beppu, Toru|Tan, Xia
PMID: 26927447
Journal: Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):27-38.
Title: RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.
Author: Fang, Bingliang
PMID: 26350096
Journal: Cancer Lett. 2017 Jan 1;384:86-93.
Title: Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.
Author: Yu, Chih-Chieh|Qiu, Wanglong|Juang, Caroline S|Mansukhani, Mahesh M|Halmos, Balazs|Su, Gloria H
PMID: 27725226
Journal: J Gastrointest Oncol. 2017 Feb;8(1):164-172.
Title: Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.
Author: Borazanci, Erkut|Millis, Sherri Z|Kimbrough, Jeffery|Doll, Nancy|Von Hoff, Daniel|Ramanathan, Ramesh K
PMID: 28280620
Journal: Mol Cancer Res. 2017 Jul;15(7):929-941.
Title: Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.
Author: Hao, Fang|Xu, Qinhong|Zhao, Yinglan|Stevens, Jan V|Young, Steven H|Sinnett-Smith, James|Rozengurt, Enrique
PMID: 28360038
Journal: Cell Rep. 2017 Jul 25;20(4):999-1015.
Title: A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.
Author: Anderson, Grace R|Winter, Peter S|Lin, Kevin H|Nussbaum, Daniel P|Cakir, Merve|Stein, Elizabeth M|Soderquist, Ryan S|Crawford, Lorin|Leeds, Jim C|Newcomb, Rachel|Stepp, Priya|Yip, Catherine|Wardell, Suzanne E|Tingley, Jennifer P|Ali, Moiez|Xu, Mengmeng|Ry
PMID: 28746882
Journal: Oncol Rep. 2017 Dec;38(6):3567-3573.
Title: MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.
Author: Chen, Qiuyang|Wang, Peng|Fu, Yue|Liu, Xinchun|Xu, Wenbin|Wei, Jishu|Gao, Wentao|Jiang, Kuirong|Wu, Junli|Miao, Yi
PMID: 29039566
Journal: Oncotarget. 2017 Jun 28;8(55):93464-93475.
Title: Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.
Author: Gleeson, Ferga C|Voss, Jesse S|Kipp, Benjamin R|Kerr, Sarah E|Van Arnam, John S|Mills, John R|Marcou, Cherisse A|Schneider, Amber R|Tu, Zheng Jin|Henry, Michael R|Levy, Michael J
PMID: 29212165
Journal: Oncogene. 2018 Feb 8;37(6):821-832.
Title: RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Author: Chen, S-H|Gong, X|Zhang, Y|Van Horn, R D|Yin, T|Huber, L|Burke, T F|Manro, J|Iversen, P W|Wu, W|Bhagwat, S V|Beckmann, R P|Tiu, R V|Buchanan, S G|Peng, S-B
PMID: 29059158
Journal: Arch Pathol Lab Med. 2018 Mar;142(3):420-423.
Title: Intraductal Tubulopapillary Neoplasm of the Pancreas: An Overview.
Author: Kim, Hyunsung|Ro, Jae Y
PMID: 29494224
Journal: Clin Cancer Res. 2018 Sep 15;24(18):4444-4454.
Title: Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.
Author: Wartenberg, Martin|Cibin, Silvia|Zlobec, Inti|Vassella, Erik|Eppenberger-Castori, Serenella|Terracciano, Luigi|Eichmann, Micha David|Worni, Mathias|Gloor, Beat|Perren, Aurel|Karamitopoulou, Eva
PMID: 29661773
Journal: Exp Ther Med. 2018 Aug;16(2):1499-1504.
Title: miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA.
Author: Zhang, Shengping|Cai, Jiarong|Xie, Wenjun|Luo, Hui|Yang, Fei
PMID: 30112070
Journal: Surg Case Rep. 2018 Aug 16;4(1):96.
Title: Intrapancreatic recurrence of intraductal tubulopapillary neoplasm (ITPN) 16 years after the initial surgery for noninvasive ITPN: a case report.
Author: Saeki, Kiyoshi|Miyasaka, Yoshihiro|Ohishi, Yoshihiro|Yamamoto, Takeo|Matsuda, Ryota|Mochidome, Naoki|Mori, Yasuhisa|Nakata, Kohei|Ohtsuka, Takao|Ishigami, Kousei|Minoda, Yosuke|Koga, Yutaka|Oda, Yoshinao|Nakamura, Masafumi
PMID: 30116990